| Nasdaq: CLSN
Celsion Corp. provides oncology drug development services. It is an oncology drug development company dedicated to the development and commercialization of cancer drugs, including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. The company's lead product, ThermoDox, is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers. Celsion was founded by Augustine Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.